Prof Paolo Muraro

Transparency under the CMA Order 2014

 

All private healthcare operators are required under the Competition and Markets Authority Order 2014 (“The CMA Order”) to be transparent about the relationship between their doctor and the private healthcare operator. Therefore, prospective patients should be aware that (in addition to being permitted to consult with and to treat patients at our facilities) this doctor also has an advisory role with HCA UK and is paid by HCA UK for this advisory role. We describe the nature of the role below, and we indicate how much the doctor has been paid for performing the role since 1 January 2023

 

Prof Muraro provides medical advisory services to HCA UK's The London Bridge Hospital in relation to the operation of the Haemotopoietic Stem Cell Transplantation (HSCT) service at the Hospital.

 

In this role, he provides an independent review of treatment outcomes and may attend meetings such as the Clinical Governance Committee and Medical Advisory Committee at the Hospital, as well as HCA UK's Medical Advisory Board.

 

He advises HCA UK in investigations, and offers guidance in the management of clinical incidents and complaints.

 

HCA UK is charged by doctors in return for their expertise and advice, including on how to operate safe hospital facilities delivering complex care. All services provided under this agreement are charged to HCA UK.

 

In 2023 the total amount paid for these services was £6,150.

 

If a doctor provides HCA UK with medical advisory services and also practises in the NHS, HCA UK requires that doctor to attest that he/she is not compromising his/her NHS commitments in so doing.